Related references
Note: Only part of the references are listed.RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues
Julian P. Venables et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Splicing-Factor Oncoprotein SRSF1 Stabilizes p53 via RPL5 and Induces Cellular Senescence
Oliver I. Fregoso et al.
MOLECULAR CELL (2013)
Topical Antiangiogenic SRPK1 Inhibitors Reduce Choroidal Neovascularization in Rodent Models of Exudative AMD
Melissa V. Gammons et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Snail Represses the Splicing Regulator Epithelial Splicing Regulatory Protein 1 to Promote Epithelial-Mesenchymal Transition
Lauren M. Reinke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Proto-oncogene PKCι Regulates the Alternative Splicing of Bcl-x Pre-mRNA
Jacqueline C. Shultz et al.
MOLECULAR CANCER RESEARCH (2012)
The Akt-SRPK-SR Axis Constitutes a Major Pathway in Transducing EGF Signaling to Regulate Alternative Splicing in the Nucleus
Zhihong Zhou et al.
MOLECULAR CELL (2012)
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
Olga Anczukow et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
K. Horiguchi et al.
ONCOGENE (2012)
Quantification of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase and Correlations with Telomerase Activity in Lung Cancer
Yan Liu et al.
PLOS ONE (2012)
Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT)
Claude C. Warzecha et al.
SEMINARS IN CANCER BIOLOGY (2012)
Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC
Shipra Das et al.
CELL REPORTS (2012)
Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer
Naoko Okumura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Elianna M. Amin et al.
CANCER CELL (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
Rhonda L. Brown et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Alternative Splicing of SLC39A14 in Colorectal Cancer is Regulated by the Wnt Pathway
Kasper Thorsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
SRSF1 Regulates the Alternative Splicing of Caspase 9 Via A Novel Intronic Splicing Enhancer Affecting the Chemotherapeutic Sensitivity of Non-Small Cell Lung Cancer Cells
Jacqueline C. Shultz et al.
MOLECULAR CANCER RESEARCH (2011)
Exon 11 Skipping of E-Cadherin RNA Downregulates Its Expression in Head and Neck Cancer Cells
Sanjai Sharma et al.
MOLECULAR CANCER THERAPEUTICS (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
Natural Splice Variant of MHC Class I Cytoplasmic Tail Enhances Dendritic Cell-Induced CD8+ T-Cell Responses and Boosts Anti-Tumor Immunity
Tania G. Rodriguez-Cruz et al.
PLOS ONE (2011)
Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1
Jes-Niels Boeckel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms
J. Woolard et al.
CHEMICAL SCIENCE (2011)
An EMT-Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
Irina M. Shapiro et al.
PLOS GENETICS (2011)
Identification of an Exon 4-Deletion Variant of Epidermal Growth Factor Receptor with Increased Metastasis-Promoting Capacity
Hai Wang et al.
NEOPLASIA (2011)
Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo
Souheila Amor et al.
BMC CANCER (2010)
Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene
Nicholas A. Olshavsky et al.
CANCER RESEARCH (2010)
Alternative Splicing of Caspase 9 Is Modulated by the Phosphoinositide 3-Kinase/Akt Pathway via Phosphorylation of SRp30a
Jacqueline C. Shultz et al.
CANCER RESEARCH (2010)
An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition
Claude C. Warzecha et al.
EMBO JOURNAL (2010)
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Charles J. David et al.
GENES & DEVELOPMENT (2010)
Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
Dawid G. Nowak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth
Maria Peiris-Pages et al.
JOURNAL OF PATHOLOGY (2010)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo
G. Merdzhanova et al.
ONCOGENE (2010)
Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways
Vania Goncalves et al.
HUMAN MOLECULAR GENETICS (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma
Jehad Abubaker et al.
JOURNAL OF PATHOLOGY (2009)
ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing
Claude C. Warzecha et al.
MOLECULAR CELL (2009)
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth
Romulo J. C. Albuquerque et al.
NATURE MEDICINE (2009)
Cancer-associated regulation of alternative splicing
Julian P. Venables et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Changes of Telomerase Activity by Alternative Splicing of Full-Length and beta Variants of hTERT in Breast Cancer Patients
Sun Young Rha et al.
ONCOLOGY RESEARCH (2009)
Protection against Retrovirus Pathogenesis by SR Protein Inhibitors
Anne Keriel et al.
PLOS ONE (2009)
Changes of the Alternative Splicing Variants of Human Telomerase Reverse Transcriptase during Gastric Carcinogenesis
Jin-Heng Xu et al.
PATHOBIOLOGY (2009)
VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma:: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
A. H. R. Varey et al.
BRITISH JOURNAL OF CANCER (2008)
The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice
E. S. Rennel et al.
BRITISH JOURNAL OF CANCER (2008)
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35
G. Merdzhanova et al.
CELL DEATH AND DIFFERENTIATION (2008)
Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo
Sebastian Oltean et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Alternative Splicing and Tumor Progression
Claudia Ghigna et al.
CURRENT GENOMICS (2008)
Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma
Steven Yea et al.
GASTROENTEROLOGY (2008)
Patterns of missplicling caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression
Katherine Zhang et al.
HUMAN MUTATION (2008)
p73 isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors:: VEGF165b downregulation as a marker of poor prognosis
Raquel Diaz et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Antagonistic effects of the SRp30c protein and cryptic 5′ splice sites on the alternative splicing of the apoptotic regulator Bcl-x
Philippe Cloutier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
Dawid G. Nowak et al.
JOURNAL OF CELL SCIENCE (2008)
Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes
Lulzim Shkreta et al.
MOLECULAR CANCER THERAPEUTICS (2008)
RBM5/Luca-15/H37 Regulates Fas Alternative Splice Site Pairing after Exon Definition
Sophie Bonnal et al.
MOLECULAR CELL (2008)
The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1
Gracjan Michlewski et al.
MOLECULAR CELL (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Qun Pan et al.
NATURE GENETICS (2008)
Alternative splicing of TGF- betas and their high-affinity receptors TβRI, TβRII and TβRIII (betaglycan) reveal new variants in human prostatic cells
Lutz Konrad et al.
BMC GENOMICS (2007)
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
R. O. Pritchard-Jones et al.
BRITISH JOURNAL OF CANCER (2007)
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Rotem Karni et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome
Valerie Anne Schumacher et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity
Sebastian Oltean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Takeshi Fukuhara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A positive feedback loop couples Ras activation and CD44 alternative splicing
Chonghui Cheng et al.
GENES & DEVELOPMENT (2006)
Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice
AP Baraniak et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene
C Ghigna et al.
MOLECULAR CELL (2005)
Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis
N Rouas-Freiss et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
DC Radisky et al.
NATURE (2005)
A novel role for shuttling SR proteins in mRNA translation
JR Sanford et al.
GENES & DEVELOPMENT (2004)
Involvement of SR proteins in mRNA surveillance
Z Zhang et al.
MOLECULAR CELL (2004)
VEGF165b, an inhibitory vascular endothelial growth factor splice variant:: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
J Woolard et al.
CANCER RESEARCH (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements
AP Baraniak et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
SR splicing factors serve as adapter proteins for TAP-dependent mRNA export
YQ Huang et al.
MOLECULAR CELL (2003)
Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade
D Himeji et al.
BLOOD (2002)
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
M Skobe et al.
NATURE MEDICINE (2001)
An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein
RP Carstens et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
